Acetylcholine stimulates alveolar macrophages to release inflammatory cell chemotactic activity

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 274, Issue 6 18-6, 1998, Pages

  Sato, Etsuro ^a   Koyama, Sekiya ^a   Okubo, Yoshio ^a   Kubo, Keishi ^a   Sekiguchi, Morie ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Calcitonin generelated peptide; Leukotriene B4; Platelet activating factor; Substance P

Indexed keywords

ACETYLCHOLINE; CALCITONIN GENE RELATED PEPTIDE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 3; INTERLEUKIN 5; INTERLEUKIN 8; LEUKOTRIENE B4; LEUKOTRIENE B4 RECEPTOR ANTAGONIST; LIPOXYGENASE INHIBITOR; MUSCARINIC M3 RECEPTOR; POLYCLONAL ANTIBODY; SUBSTANCE P; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST;

ANIMAL CELL; ARTICLE; CATTLE; CHEMOTAXIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; EOSINOPHIL; INFLAMMATORY CELL; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; MONOCYTE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION;

EID: 0031778288     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.1998.274.6.l970     Document Type: Article

References (42)

1. Armour, C. L., J. M. Hughes, J. P. Seale, and D. M. Temple. Effect of lipoxygenase inhibitors on release of slow-reacting substances from human lung. Eur. J. Pharmacol. 72: 93-96, 1981.
2. Arnoux, B., M. H. S. Caeiro, A. Landes, M. Mathieu, P. Duroux, and J. Benveniste. Alveolar macrophages from asthmatic patients release platelet-activating factor (PAF-acether) and lyso-paf-acether when stimulated with the specific allergen (Abstract). Am. Rev. Respir. Dis. 125: A70, 1982.
3. Atkins, P. C., M. Valenzano, E. J. Goetzl, W. D. Ratnoff, F. M. Graziano, and B. Zweiman. Identification of leukotriene B4 as the neutrophil chemotactic factor released by antigen challenge from passively sensitized guinea pig lungs. J. Allergy Clin. Immunol. 83: 136-143, 1989.
4. Bachwich, P. R., J. P. Lynch, J. Larrick, M. Spengler, and S. L. Kunkel. Tumor necrosis factor production by human sarcoid alveolar macrophages. Am. J. Pathol. 125: 421-425, 1986.
5. Behrens, B. L., R. A. F. Clark, D. C. Feldsien, D. M. Presley, L. S. Glezen, J. P. Graves, and G. L. Larsen. Comparison of the histopathology of the immediate and late asthmatic and cutaneous responses in a rabbit model. Chest 87: 153S-155S, 1985.
6. Boyum, A. Isolation of mononuclear cells and granulocytes from human blood. Scand. J. Clin. Lab. Invest. 21: 77-89, 1968.
7. Clark, A. L., and F. Mitchelson. The inhibitory effect of gallamine on muscarinic receptors. Br. J. Pharmacol. 58: 323-331, 1976.
8. Clark, P. O., D. J. Hanahan, and R. N. Pinckard. Physical and chemical properties of platelet-activating factor obtained from human neutrophils and monocytes and rabbit neutrophils and basophils. Biochim. Biophys. Acta 628: 69-75, 1980.
9. Couture, R., and A. C. Cuello. Studies on the trigeminal antidromic vasodilatation and plasma extravasation in the rat. J. Physiol. (Lond.) 346: 273-285, 1984.
10. Goldberg, I. H. Mode of action of antibiotics. II. Drugs affecting nucleic acid and protein synthesis. Am. J. Med. 39: 722-752, 1965.
11. Gross, N. J., and M. S. Skorodin. Anticholinergic, antimuscarinic bronchodilators. Am. Rev. Respir. Dis. 129: 856-870, 1984.
12. Gross, N. J., and M. S. Skorodin. Role of the parasympathetic system in airway obstruction due to emphysema. N. Engl. J. Med. 311: 421-425, 1984.
13. Hammer, R., C. P. Berrie, N. J. Birdsall, A. S. Burgen, and E. C. Hulme. Pirenzepine distinguishes between different subclasses of muscarinic receptors. Nature 283: 90-92, 1980.
14. Hansel, T. T., I. J. De Vries, T. Iff, S. Richs, M. Wandzilak, S. Betz, K. Blaser, and C. Walker. An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils. J. Immunol. Methods 145: 105-110, 1991.
15. Harvath, L., W. Falk, and E. J. Leonard. Rapid quantitation of neutrophil chemotaxis: use of a polyvinylpyrrolidone-free polycarbonate membrane in a multiwell assembly. J. Immunol. Methods 37: 39-45, 1980.
16. Jancso, N., A. Jancso-Gabor, and J. Szolcsanyi. Direct evidence for neurogenic inflammation and its prevention by denervation and by pretreatment with capsaicin. Br. J. Pharmacol. 31: 138-151, 1967.
17. Janoff, A., B. Sloan, G. Weinbaum, V. Damiano, R. A. Sandhous, J. Elias, and P. Kimbel. Experimental emphysema induced with purified human neutrophil elastase: tissue localization of the instilled protease. Am. Rev. Respir. Dis. 115: 461-478, 1977.
18. Kay, A. B. Asthma and inflammation. J. Allergy Clin. Immunol. 87: 893-910, 1991.
19. Kishikawa, K., N. Matsunaga, T. Maruyama, R. Seo, M. Toda, T. Miyamoto, and A. Kawasaki. Ono-LB-457: a novel and orally active leukotriene B4 receptor antagonist. Adv. Prostaglandin Thromboxane Leukot. Res. 21: 407-410, 1991.
20. Kishikawa, K., N. Tateishi, T. Maruyama, R. Seo, M. Toda, and T. Miyamoto. Ono-4057, a novel, orally active leukotriene B4 antagonist: effects on LTB4-induced neutrophil functions. Prostaglandins 44: 261-275, 1992.
21. Koyama, S., S. I. Rennard, S. Shoji, D. Romberger, J. Linder, R. Ertl, and R. A. Robbins. Bronchial epithelial cells release chemoattractant activity for monocytes. Am. J. Physiol. 257 (Lung Cell. Mol. Physiol. 1): L130-L136, 1989.
22. Lee, T. H. Interactions between alveolar macrophages, monocytes, and granulocytes. Implications for airway inflammation. Am. Rev. Respir. Dis. 135, Suppl.: S14-S17, 1987.
23. Lembeck, F., J. Donnerer, and L. Bartho. Inhibition of neurogenic vasodilation and plasma extravasation by substance P antagonists, somatostatin, and [D-Met2, Pro5] enkephalinamide. Eur. J. Pharmacol. 85: 171-176, 1982.
24. Mann, J. S., and C. F. George. Anticholinergic drugs in the treatment of airways disease. Br. J. Dis. Chest 79: 209-228, 1985.
25. Martin, T. R., G. Raugi, T. L. Merritt, and W. R. Henderson, Jr. Relative contribution of leukotriene B4 to the neutrophil chemotactic activity produced by the resident human alveolar macrophage. J. Clin. Invest. 80: 1114-1124, 1987.
26. Mathews, W. R., and R. C. Murphy. Inhibition of leukotriene biosynthesis in mastocytoma cells by diethylcarbamazine. Biochem. Pharmacol. 31: 2129-2132, 1982.
27. Mornex, J. F., Y. Martinet, K. Yamauchi, P. B. Bitterman, G. R. Grotendorst, A. Chytil-Weir, G. R. Martin, and R. G. Crystal. Spontaneous expression of the c-sis gene and release of a platelet-derived growth factor like molecule by human alveolar macrophages. J. Clin. Invest. 78: 61-66, 1986.
28. Murphy, K. R., M. C. Wilson, C. G. Irvin, L. S. Glezen, W. R. Marsh, C. Haslett, P. M. Henson, and G. L. Larsen. The requirement for polymorphonuclear leukocytes in the late asthmatic response and heightened airways reactivity in an animal model. Am. Rev. Respir. Dis. 134: 62-68, 1986.
29. Page, C. P. The role of platelet-activating factor in asthma. J. Allergy Clin. Immunol. 81: 144-152, 1988.
30. Powell, W. S. Rapid extraction of arachidonic acid metabolites from biological samples using octadecylsilyl silica. Methods Enzymol. 86: 467-477, 1982.
31. Salari, H., and M. Chan-Yeung. Release of 15-hydroxyeicosatetraenoic acid (15-HETE) and prostaglandin E2 (PGE2) by cultured human bronchial epithelial cells. Am. J. Respir. Cell Mol. Biol. 1: 245-250, 1989.
32. Salmon, J. A., P. M. Simmons, and R. M. Palmer. A radioimmunoassay for leukotriene B4. Prostaglandins 24: 225-235, 1982.
33. Sato, E., S. Koyama, H. Nomura, K. Kubo, and M. Sekiguchi. Bradykinin stimulates alveolar macrophages to release neutrophil, monocyte, and eosinophil chemotactic activity. J. Immunol. 157: 3122-3129, 1996.
34. Sekizawa, K., M. Yanai, Y. Shimizu, H. Sasaki, and T. Takishima. Serial distribution of bronchoconstriction in normal subjects: methacholine versus histamine. Am. Rev. Respir. Dis. 137: 1312-1316, 1988.
35. Tamaoki, J., M. Kondo, N. Sakai, J. Nakata, H. Takemura, A. Nagai, T. Takizawa, and K. Konno. Leukotriene antagonist prevents exacerbation of asthma during reduction of high-dose inhaled corticosteroid. Am. J. Respir. Crit. Care Med. 155: 1235-1240, 1997.
36. Terashita, Z., M. Kawamura, M. Takatani, S. Tsushima, Y. Imura, and K. Nishikawa. Beneficial effects of TCV-309, a novel potent and selective platelet activating factor antagonist in endotoxin and anaphylactic shock in rodents. J. Pharmacol. Exp. Ther. 260: 748-755, 1991.
37. Tomioka, H., C. Ra, I. Iwamoto, T. Sato, K. Kodama, S. Yoshida, M. Tanaka, and S. Yoshida. Arachidonic acid metabolism of human granulocytes from asthmatic patients. Adv. Prostaglandin Thromboxane Leukot. Res. 15: 339-343, 1985.
38. Walz, A., P. Peveri, H. Aschauer, and M. Baggiolini. Purification and amino acid sequencing of NAF, a novel neutrophil-activating factor produced by monocytes. Biochem. Biophys. Res. Commun. 149: 755-761, 1987.
39. Ward, P. A., C. B. Cochrane, and J. J. Muller-Eberhard. The role of serum complement in chemotaxis of leukocytes. J. Exp. Med. 122: 237-246, 1965.
40. 3H]acetylcholine in human isolated bronchi. Am. J. Respir. Crit. Care Med. 151: 1040-1046, 1995.
41. Yager, H., R. M. Weinberg, L. V. Kaufman, and S. Katz. Asthma: comparative bronchodilator effects of ipratropium bromide and isoproterenol. J. Clin. Pharmacol. 16: 198-204, 1979.
42. Zigmond, S. H., and J. G. Hirsch. Leukocyte locomotion and chemotaxis: new methods for evaluation and demonstration of a cell-derived chemotactic factor. J. Exp. Med. 137: 387-410, 1973.